Accusing China of ‘vaccine diplomacy’ is simply groundless


In this Dec 6 photo released by the Indonesian presidential palace, Chinese company Sinovac’s vaccine is being loaded onto an Indonesian plane at the Beijing International Airport. — AP

DESPITE the good news that Covid-19 vaccines have been effective in trials, the life-saving products have, time and again, been politicised by certain Western politicians, who portray China’s vaccines as a bargaining chip to expand political influence.

“Vaccine diplomacy” is the term Western critics often like to use. They claim that the vaccine has become a tool to increase China’s global influence and iron out geopolitical issues.

The latest accusation of China’s “vaccine diplomacy” comes after allegations like “Covid-19 originated in a lab in Wuhan” and “mask diplomacy, ” which have the same intention. Going by their nature, they are in line with their bias against China.

These voices, however, do not represent the mainstream view.

Packages of Covid-19 inactivated vaccine products at a production plant of the Beijing Biological Products Institute Co Ltd, a unit of state-owned Sinopharm in Beijing. — AP
Packages of Covid-19 inactivated vaccine products at a production plant of the Beijing Biological Products Institute Co Ltd, a unit of state-owned Sinopharm in Beijing. — AP

China has made the solemn and consistent commitment that once developed and deployed, its vaccines will be made global public goods and supplied to the world at fair, reasonable prices.

Xulio Rios, director of the Observatory of Chinese Politics in Spain, said China has been accused of using the Covid-19 vaccine as a strategic tool to silence criticism, but this is not the case. Some Western countries want to win the vaccine race at all costs, and that’s why they denigrate China for no reason.

The fact is that China, one of the first few countries to begin developing a Covid-19 vaccine, did not develop the jab with the purpose of spreading political influence in the world.

What China has done is actually promote international cooperation in vaccines. As early as May 2020, China had promised that Covid-19 vaccine development and rollout in the country will be made a global public good, which will be China’s contribution to ensuring vaccine accessibility and affordability in developing countries.

Since the Covid-19 outbreak, China has adopted five technological approaches to developing the vaccines. By Dec 2,2020, the country had five Covid-19 vaccines entering phase three clinical trials.

China has approved the domestic emergency use of its vaccines, and there hasn’t been any severe adverse reaction so far.

Recently, the United Arab Emirates and Bahrain approved the registration of a Covid-19 vaccine developed by Sinopharm and proposed to purchase Chinese vaccines.

Studies showed that China-made vaccines can be more easily stored and delivered via the current cold-chain system, indicating greater accessibility without extra delivery cost.

All this proves the safety and effectiveness of Chinese vaccines as well as the regulatory authority’s observance of international customary practice and laws.

Making real progress in the cause of human rights lies in concrete actions, not political showmanship. That is why China has all along maintained close communication and cooperation with the World Health Organisation (WHO) and Gavi, the Vaccine Alliance.

While most countries worldwide are pooling efforts to develop and distribute vaccines, the world must guard against the emergence of vaccine nationalism.

The world can stabilise health systems and rebuild the global economy only when those at highest risk from the virus everywhere and at the same time are protected, World Health Organisation

director-general Tedros Adhanom Ghebreyesus once said.

“Like an orchestra, we need all instruments to be played in harmony to create music that everyone enjoys, ” he said. – Xinhua

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Focus

Malaysia’s data centres, costs and spillovers
When seeing is no longer believing
The trust between you and AI
Pragmatic autonomy: Navigating the next chapter of Malaysia-US defence ties
When AI-deas run wild
Cybersecurity risks may lurk beyond a company’s walls
Malaysia Mamdani dreams: Filling in our potholes
The break-up that hurts both sides
Fleeting calm amid loss and ruin
Putting the squeeze on America’s favourite fruit

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read